chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a 62-year-old man with a past medical history of metastatic spindle cell cancer status post recent bronchoscopy for tumor debulking on 2/2/2022 with known left-sided malignant bronchial obstruction, recent new heart failure with reduced ejection fraction who presents via EMS from home for respiratory distress. EMS reports he started out with oxygen saturations in the 70s and talking to them he progressed to unresponsiveness and unable to obtain a stat. They tried treating him with albuterol followed by CPAP followed by bag-valve-mask ventilations which they were doing on arrival. On arrival he was undergoing bag-valve-mask ventilations, on transfer over to our stretcher he became pulseless after briefly becoming bradycardic. CPR was immediately started. An LMA was placed. Epinephrine was given x3. A right humeral 10 was placed. Intubation was performed. Shortly after intubation and return of spontaneous circulation he had a wide tachycardic rhythm. He was synchronized cardioverted at 200 J with no change in rhythm. He was started on epinephrine drip. He was given calcium and bicarb during the rest as well. Chest x-ray shows good positioning of the endotracheal tube, his end-tidal to was coming down from 100 to the 60s. Chest x-ray does also show significant white out of the left lung. He will be given broad-spectrum antibiotics.  On arrival to MICU he became hypotensive and once again had wide complex tachycardia so amiodarone was given and his HR improved to 90 bpm. Changed from epinephrine drip to norepinephrine drip. Treated with Vancomycin and Zosyn for broad spectrum ABX. Continued IV amiodarone load without oral maintenance dose. Notably, he was able to follow simple commands and seemed neurologically intact after his cardiac arrest. He was extubated to BiPAP on 02/16. He had hyperkalemia that was managed with lokelma and IV insulin. Our team and palliative care facilitated ongoing GOC discussion with patient and his family, and ultimately it was decided to pursue comfort care. Patient passed away with his family at bedside
Patient received seasonal flu shot 9/18/09. Patient experienced dizziness. Vertigo associated with head movement and headache 24 hours after shot.
Patients who received expired doses of the Moderna COVID vaccine; Vaccines placed in refrigerator on 1/13/22 and dose admistered to patient on 2/17/22; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients who received expired doses of the Moderna COVID vaccine) and PRODUCT STORAGE ERROR (Vaccines placed in refrigerator on 1/13/22 and dose admistered to patient on 2/17/22) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 068H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2022, the patient experienced PRODUCT STORAGE ERROR (Vaccines placed in refrigerator on 1/13/22 and dose admistered to patient on 2/17/22). On 17-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients who received expired doses of the Moderna COVID vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients who received expired doses of the Moderna COVID vaccine) and PRODUCT STORAGE ERROR (Vaccines placed in refrigerator on 1/13/22 and dose admistered to patient on 2/17/22) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.
Had a sore arm for a couple of days; This is a spontaneous report from a contactable consumer (patient).   A 75-year-old female patient received BNT162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on an unspecified date as dose 1, single and received BNT162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunization. Patient relevant medical history includes allergic to penicillin and allergic to sulfa. The patient concomitant medications were not reported. The patient received the first and second dose of the vaccine and was scheduled to get the booster. Patient asked if the ingredients was the same in the booster as the first two doses. The patient was allergic to Penicillin and Sulfa so the patient wants to make sure it was the exact same thing. The patient had a sore arm for a couple of days with the first two doses. The outcome of the event was unknown.   No follow-up attempts are possible. No further information expected
Hours after receiving the shot,  patient experienced dizziness, sluggishness, whole body aches, foggy thoughts, impaired functioning, and swollen and sore at injection site.  Symptoms continued and she felt very sick for 3 days. On the third day, she went to urgent care and was given Z-pack.
Chills, freezing cold, couldn't get warm-felt this way last year with same brand of vaccine. Goose bumps, teeth chattering-sleepy-fever of 102-took ADVIL and felt better - continued with chills for one day - fever came back up to 100. Next day felt better - temp 98.8, fatigue.
Skin rash appeared on face, then on sides of stomach, and on the forearms. The rashes were red, usually small itchy bumps. This lasted for several days and was treated with cortisone cream.
Patient said after the vaccine he started to feel achy in his legs and knees.  He also felt like the top of his ears and eye lids were hurting and tingly.  He did also mention that he had a sore arm at the injection site.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Apr2021 as dose 1, single (Lot number: EW0164), in left arm, on 22May2021 as dose 2, single (Lot number: EW0185), in right arm and on 22Nov2021 as dose 3 (booster), single (Lot number: 330268D) at the age of 49 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Negative, notes: I had a negative COVID test after 4 days on Paxlovid; (Jul2022) positive, notes: But my symptoms returned and I tested positive a week and a half later. Therapeutic measures were taken as a result of covid-19.  Clinical course: Paxlovid rebound. Patient had a negative COVID test after 4 days on Paxlovid. But her symptoms returned and tested positive a week and a half later.  No follow-up attempts are possible. No further information is expected.
Few hours after I experienced arm soreness.  12hrs after vaccination experienced chills, and high fever for hours.  Fatigue. 24 hrs later arm an muscle soreness an fatigue  48 hrs later left neck muscle pain and swelling like a kinked neck and finally has gone down now at 96 hours after vaccination. Still soreness in left arm  72 hours after vaccination I have fever blisters inside bottom of my lip Still soreness in left arm and very small amount of neck soreness
headache; tinnitus in his hearing; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 03Oct2022 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: HEADACHE (non-serious), outcome "unknown"; TINNITUS (non-serious), outcome "unknown", described as "tinnitus in his hearing". Therapeutic measures were taken as a result of headache, tinnitus. Additional information: Patient said that after his PFIZER vaccine he had severe headache and tinnitus in his hearing. Treatment: paracetamol  Follow-up attempts are completed. No further information is expected.
I started itching while being monitored post vaccine administration within the 5 minutes of the vaccine being administered. The itching was everywhere including my tongue and throat, since this is my workplace and I was working I had to go home and was given Benadryl to take upon arrival, the Benadryl did not help so I did a virtual visit with a physician who recommended that I increase the dose of benadryl at the same time I called my PCP to inform them of the issue they ordered, Atarax 25 mg every 6 hours plus taking an over the counter antihistamine.
nose was clogged; sinus infection; A spontaneous report was received from a consumer concerning a 69-year-old, female patient, participating in the Moderna's COVID-19 vaccine (mRNA-1273) Emergency Use Program  who had experienced sinus infection, and her nose was clogged.  The patient's medical history, was not provided by the reporter.   Concomitant medications were not reported.    The patient received their first of two planned dose of mRNA-1273 on 2/Feb/2021. Prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 in(Lot number: unknown) for prophylaxis of COVID-19 infection .   Experienced sinus infection, and her nose was clogged.   No lab data was reported by the reporter.   Action taken with mRNA-1273 in response to the events was not reported.     The outcome of events, sinus infection, and her nose was clogged were unknown.   The reporter did not provide an assessment for the events,sinus infection, and her nose was clogged.  Since no Seriousness criteria is reported , hence the case is considered to be Non-serious.
spontaneous vomiting; experienced diarrhea; This case was reported by a consumer via call center representative and described the occurrence of vomiting in a 52-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced vomiting and diarrhea. On an unknown date, the outcome of the vomiting and diarrhea were recovered/resolved.   It was unknown if the reporter considered the vomiting and diarrhea to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that she received flu vaccine 10-13 years ago and she experienced diarrhea and spontaneous vomiting which resolved in 2-3 days. The reporter did not consent to follow up.
rec'd vaccine Tdap 1-29-10 on 2-1-10 pt called and stopped by office c/o R LBP and pain radiating down R LE and up R T-spine
1 1/2 hr after vaccine administration, child pulled the pants down. Looked at the band aid and cried - saying shot was given. She almost lost consciousness - fell down. Dad held her and shook her and she became alert and conscious. Lasted for 10 sec. After that she had low grade fever.
Pt received vaccines in arm on 10/15 by 11 PM that night developed low grade temp, pt reported taking Tylenol that am and fever increased to 103 by that afternoon, on 10/17 had elevated fever and went to ER = (-) swab (-) meningitis (+) high WBC + local rx develop et treated with AIB and fluids - sent home 10/17 symptom subsided 10/20/19 Pt reported cellulitis per ER
1/27/2010  Arm swollen/sore/red.  Fever, back/body aches, felt like being choked, neck glands swollen.  1/28/2010  Fever of 101, neck/glands swollen, tight in neck.  1/29/2010  Sore throat, achy all over, neck/glands swollen, difficulty breathing.  Rigors from 1/27/2010. Feeling of impending doom.
R.N. was unable to locate deltoid properly - flu vaccine erroneously given in left shoulder joint. Within 1/2 hr. patient developed warmth, numbness and pain at injection site and warmth, stiffness in left face and axillary area.
This case was reported by a nurse via a wholesaler sales representative and described the occurrence of low seroconversion to hepatitis b vaccine in subject of unspecified age and gender who was vaccinated with Engerix-B for prophylaxis. It was thought that the subject completed the entire series of Engerix-B (vaccination dates not provided), but it was unclear. At an unspecified time after vaccination with Engerix-B, the subject's titer did not reach the correct level, and the subject developed possible lack of efficacy. At the time of reporting, the outcome of the events was unspecified.
Information has been received from a female consumer, who is a registered nurse, who in 1992 was vaccinated with a dose of hepatitis B virus vaccine. Subsequently, the nurse developed thrombocytopenia and was hospitalized for one week. There was no product quality complaint involved. Additional information has been requested.
This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Received a half dose for the 2nd dose of the Moderna COVID-19 vaccine) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.No Medical History information was reported.On 22-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced ACCIDENTAL UNDERDOSE (Received a half dose for the 2nd dose of the Moderna COVID-19 vaccine). On 22-Nov-2021, ACCIDENTAL UNDERDOSE (Received a half dose for the 2nd dose of the Moderna COVID-19 vaccine) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.No concomitant medications was reported.No treatment drug details was reported.This case was linked to MOD-2021-395761 (Patient Link).
Reported adverse effects to J&J after a horrible day/night from severe allergic reaction. We were 5 hrs from home, on a weekend, could not get vaccines in our county. Drove to  County. After the 15 min when walking out of the building noticed strong metallic taste in mouth (no fillings), thought odd. Then while driving noticed red blemishes/rash on neck, swelling of my tongue. Once arrived at hotel (too far to drive back home and not feeling well), noticed red rash on front of neck, ear lobes bright red, hot to the touch and swollen. Vertigo and low fever came on along with elevated heart rate. These lasted all Saturday into Sunday. Didn't and couldn't sleep Saturday night, Sunday morning rash on face with heart rate BPM elevated all day with fever and bad vertigo. All these symptoms continued all week with exception to the rash and swollen tongue those subsided late Sunday. The vertigo, fevers, skin sensitivity and complete fatigue along with bump at injection site persisted even to today.
Patient developed papular itching rash at site of injection (thighs bilaterally) spreading over thigh region - resolving spontaneously. No erythema or warmth noted. Occurred at age 2 mos, 4 mos, 6 mos. Vaccines reaction observed.
I started having symptoms on December 24, and tested for COVID and it was negative, I tested again on the morning of the 25th and it was positive. I developed a fever and I was really tired and I had a headache. I received care later, I was already 10 days out by the time I received care so I wasn't tested at the urgent care. I was prescribed albuterol, and benzonatate. I had a lot of congestion, fever for 5 days, body aches and diarrhea. The symptoms ranged from 2 weeks to a month.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2014, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. Later in 2014, the patient was treated at a medical facility for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX, for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering and other damages. Additional information has been requested.
Pain and swelling in arm where injection was received. Lymph nodes in axilla and in neck were also swollen and painful. Eyes were described as "glassy",  Two medications prescribed Lidocaine Patch and Naproxen
AUTOIMMUNE DISEASE; This spontaneous report received from a consumer via a company representative via social media concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin was not reported, batch number: unknown, expiry: unknown) dose was not reported, 1 total, administered on an unspecified date for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced autoimmune disease. It was reported that, "My friends' daughter now is suffering with an Auto immune disease." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of autoimmune disease was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20220313555 and 20220313549.; Sender's Comments: V0:20220313665-COVID-19 VACCINE AD26.COV2.S-Autoimmune disease. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Information has been received from a physician concerning a 24 year old female who in December 2006, was vaccinated intramuscularly with her first dose of GARDASIL (lot # not reported). The patient received the other two doses on unspecified dates and was sexually active during the time frame when she received all three doses. The patient became sexually active in August of 2007 and had a negative STD screen. In January 2008, the patient experienced an abnormal pap that showed low grade squamous suspicion for high grade. In February 2008, the patient underwent a colposcopy and 2 sites were found with moderate dysplasia. The patient's abnormal pap smear persisted. Additional information has been requested.
One pox lesion appeared the morning of 8/7/12. Two more appeared with 24 hours, then there have consistently been 3-4 new lesions per day. Most scab over within 24 hours. Lesions do not appear to be causing discomfort or itching, but other symptoms have been observed. Patient has had severely disrupted sleep patterns compared to before the vaccination, mood swings more than typical for him, and loss of appetite.
Woke up from nap, per babysitter she was hot then cold quickly, was shivering, had a transient rash all over body and lips got dark. Daycare lady picked her up and was fine symptoms resolved within 5 minutes, little fussier than normal.
I have mild to moderate tinnitus. My tinnitus became moderate to loud following the injection (began one day after I received the jab) and has not subsided since.
Extreme swelling in arm pit and breast area; hot to touch areas swollen; Dose Number: 3; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 47 year-old female patient received BNT162b2 (BNT162B2), administered in arm right, administration date 27Dec2021 14:00 (Lot number: FE3594) at the age of 47 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Keflex, reaction(s): "Known allergies: Keflex", notes: Known allergies: Keflex. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ER8732, Location of injection: Arm Right, Vaccine Administration Time: 12:00 PM), administration date: 01May2021, when the patient was 47 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8732, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 10Apr2021, when the patient was 47 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 27Dec2021 14:00, outcome "unknown", described as "Dose Number: 3"; SWELLING (non-serious) with onset 28Dec2021 12:00, outcome "not recovered", described as "Extreme swelling in arm pit and breast area"; FEELING HOT (non-serious) with onset 28Dec2021 12:00, outcome "not recovered", described as "hot to touch areas swollen". It was unknown if therapeutic measures were taken as a result of swelling, feeling hot.  Additional information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID prior to vaccination and since the vaccination.  No follow-up attempts are possible. No further information is expected.
In 5 days after the vaccination the upper LEFT arm has become very painful and slightly swallen. Application of ice and massaging did not help. Tylenol 325 mg was taken every 6 hours for two days. The pain and swallenness have subsided. However, the muscles of the upper left arm continue to be painful while moving the arm and they must have contracted as the range of motion of the arm is limited now comparing to the pre-vaccination time. The muscles are still painful when trying to stretch the arm. The arm became noticeably weaker. NOTE: the report cannot be ascribed to a local infection by the needle, because the same result has occurred to the RIGHT upper arm after the first vaccine dose reported to VAERS.
Suffered a miscarriage at 8 weeks gestation on August 11, 2021 after receiving the Moderna COVID-19 vaccine. Miscarriage was confirmed at Hospital on August 20, 2021. I was unaware that I was pregnant when I received the vaccine.